Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Kaumil Gajrawala
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).
- Questions
- 62on tracked calls
- Challenge rate
- 19%12 of 62 questions
- Companies
- 11questioned at least once
- Reporting periods
- 9with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 62 of 62 questions from 11 companies
PEPPepsiCo9 questions · 8 reporting periods · 2 of 9 challenging
Calendar 2026 Q3
Then on beverages, the word urgency you have used many times. What does that mean?
Show response
Laguarta defined urgency as cutting non-growth costs, funding brands and raising execution standards, while reviewing partnerships and execution choices.
what exactly is the plan? Which direction are you, what is the correct direction of travel?
Show response
Laguarta said pricing will blend revenue management and productivity to absorb new inflation while staying affordable; no explicit direction on list price.
Calendar 2026 Q2
I'm just struggling a little bit to understand what optimizing return on investment means.
Show response
Laguarta clarified it means maximizing volume from trade investments customer-by-customer and holiday-by-holiday: simpler on everyday-low-price accounts, more complex on high-low where tweaks are focused.
Calendar 2026 Q1
you had mentioned the very substantial increase in the number of occasions. Can you maybe dig into that a little bit more
Show response
Ramon described two consumer types: lapsed buyers returning through optimized value in multipacks, and new category entrants attracted by innovations like Naked and Gatorade with no artificial ingredients.
Calendar 2025 Q4
is this within the salty-snack aisle, or with the incremental shelf space, maybe in other parts of the store
Show response
Ramon confirmed gains in both main shelf and perimeter, driven by increased unit throughput from affordability investments requiring more store capacity for in-store and online fulfillment.
Calendar 2025 Q3
To what degree are you open to the idea of franchising some of these operations on the beverage side
Show response
Ramon said open to all ideas and all perspectives, but framed answer around three strategic considerations: future demand patterns (digital, delivery), technology enablement, and full PepsiCo P&L optimization. Did not commit to specific refranchising plans.
Calendar 2025 Q2
that was quite the tease on the big launch in protein. There is anything you could add
Show response
Ramon confirmed protein launch coming in a few months but declined specifics for competitive reasons. Jamie noted affordability is being addressed with much more precision by channel, pack size, and time of month.
Calendar 2025 Q1
what do you think about the launch of GLP-1 oral medications coming to market next year
Show response
Ramon noted GLP-1 consumers driving more protein, fiber, and hydration consumption; PEP well-positioned in fiber and hydration but innovating in protein. Current adoption around 7-8%.
Calendar 2024 Q4
I just wonder if these restructurings are maybe a prelude to something bigger down the road or maybe what's your appetite for that
Show response
Ramon explained the restructuring rationale as capturing international growth with focused organizations and US cost efficiencies, not a prelude to a split.
PGThe Procter & Gamble Company9 questions · 8 reporting periods · 0 of 9 challenging
Calendar 2026 Q2
Are those real run rates or do you feel like you can pick them up?
Show response
Schulten confirmed the base assumption is stable category growth and explained the sequence varies by category, using baby care value correction versus innovation-led category lift as the contrast.
Calendar 2026 Q1
it's not just commodity costs, but all the other sort of things that come with it as part of that $1 billion
Show response
Andre broke down the $1B into four components: petro-based feedstock costs, less efficient sourcing lanes with higher transportation, reformulation upcharges, and finished product logistics from diesel.
we're starting to see some public companies, especially in their filings, talk about potential tariff refunds
Show response
Andre confirmed about $150M after tax in potential IEEPA tariff refunds available but said recoverability depends on the U.S. administration laying out the process.
Calendar 2025 Q4
to the extent that you're able to calculate what actual usage is in the households, has that sort of trended off
Show response
Andre said volume slow/flat through H1; improving value proposition without price changes key to reigniting usage and penetration; slow recovery expected.
Calendar 2025 Q3
Was there anything onetime in there as it relates to sort of a near-term benefit from flipping
Show response
Andre said no one-time effects; tariff relief came from broad exemptions on non-U.S. grown materials; benefits expected to accelerate.
Calendar 2025 Q2
is there a bit of a philosophical pivot or shift in any way that would be related to the timing of this
Show response
Jon denied any philosophical pivot; attributed superiority gaps partly to cheap high-quality Chinese supply flowing into global markets.
Calendar 2025 Q1
is it slowing your, you know, the pace of innovation rollouts or expectations from contribution of those innovations
Show response
Andre said innovation pace unchanged; focus is on simplicity and restaging, working with retailers on shelf simplification.
Calendar 2024 Q4
if we can maybe dig in a little bit more on consumer health or healthcare, it's -- the comp was a bit easier
Show response
Jon attributed softness to a mild cough-cold season, but said share is still being built within cough-cold.
Calendar 2024 Q3
are you seeing trading down? How you're thinking about that in the context of promotional activity
Show response
Andre described a stable, below-pre-COVID promo environment, no trading down, and flat private-label share; no material destocking.
CLXClorox8 questions · 7 reporting periods · 2 of 8 challenging
Calendar 2026 Q2
Why not maybe a higher figure for investment as you just to assure that you don't end up back in the situation
Show response
Linda argued FY2026 bumpiness stemmed from ERP/operational disruption, not underinvestment, and that spend is targeted and adequate.
Calendar 2025 Q4
Can you maybe just talk about what you should be able to do now, what you see, maybe some cadence of benefits that flow through
Show response
Luc: Remainder of year focused on stabilizing (incremental costs go away by Q4). Then optimization phase: redesign processes, reskill workforce. Benefits in supply chain (manufacturing, logistics) both P&L and balance sheet plus admin automation. Accelerating global business services adoption. All feeds pipeline of 25-50bps annual EBIT margin expansion. Gross margin expansion generally in line with EBIT expansion.
Calendar 2025 Q3
When you're making adjustments for it, how do you feel about your market shares? Are they trending in a direction that you prefer the opposite?
Show response
Luc unpacked: -3% ex-ERP = -1% underlying + 1pt timing benefit - 3pts out-of-stock headwind. Linda said share declined more than expected due to ERP ramp-up, particularly August. Not satisfied but fundamentals strong (household penetration stable, consumer value metric high). Laser-focused on recovery.
Calendar 2025 Q2
we're hearing from yourselves and other household goods companies on a weak consumer, but we're also hearing the opposite from a lot of other industries
Show response
Linda said consumer fundamentals are fine but uncertainty is driving wallet trade-offs. Consumers buying experiences and convenience (wipes 40% Scentiva growth) while conserving on some essentials. One wallet managing multiple priorities. Not structurally unhealthy, under stress from uncertainty.
Calendar 2025 Q1
when I look between divisions, and I see that how much more it seemed to impact households than some of the other divisions
Show response
Linda explained retail sales (consumption) was similar across portfolio, Household sales gap driven by: retailer inventory adjustments in heavy goods, Kingsford timing/weather, Litter lapping prior-year promo. Not structurally different from other categories.
Calendar 2024 Q4
Can you maybe just give some more details on this 1% to 2% from turning ERP on, just -- I just don't -- I guess, I don't understand how it works from a practical perspective.
Show response
Luc explained U.S. ERP go-live July with phased manufacturing transition over six months. Shipping ahead of consumption to retailers + building own safety stock in Q4. Reverses in front half FY2026.
Calendar 2024 Q3
as you're thinking about how to get the consumer to come back, promos is a piece of it, but I suppose marketing is also quite a large piece of it
Show response
Linda described multi-pronged approach: new advertising, digital claims, subscription re-engagement, plus innovation plans for back half. Strategy working but more to come.
I was asking about ERP and what you've learned so far from Canada and what the timeline looks like for the U.S.
Show response
Linda said Canada ERP went smoothly; retailers barely noticed. U.S. implementation much more complex, to begin end of FY2025 with phased approach.
KOThe Coca-Cola Company7 questions · 7 reporting periods · 2 of 7 challenging
Calendar 2026 Q2
Is it fair to say you should be towards the high end of that at a base level
Show response
Murphy explicitly committed to the higher end of the 4% to 6% algorithm as the ambition on a sustained basis.
Calendar 2026 Q1
for the first time this emergence of what seems like an entirely new channel with the Dutch Bros and brews of the world
Show response
Henrique defended McDonald's relationship as intact, highlighted Sprite Berry Blast and Lunar Splash performing well in craft beverage space, deflected specifics on Red Bull.
Calendar 2025 Q4
So making adjustments there, it looks like quite a slowdown
Show response
John cited three factors: top line reflects momentum plus recovery needed in key markets, bias to invest ahead of the curve in brands and capabilities, and structural cycling plus below-the-line items from Coca-Cola Consolidated divestiture.
Calendar 2025 Q3
Can we dig a little more maybe on the consumer and CPG, particularly in the U.S. and Europe
Show response
James distinguished beverage industry as structural growth category (4-5% annually for decades). Plans AI and agentic tech-driven productivity plus 2026 restructuring to fund continued growth.
Calendar 2025 Q2
Can you maybe just talk about the operating leverage across the P&L given how much has changed so far
Show response
John noted G10 hedges somewhat offsetting actual dollar weakness. EM currencies less hedged. Will provide 2026 FX outlook on October call.
Calendar 2025 Q1
since John and James your arrival, it's been about dollar based growth and worked very hard to be able to grow earnings in dollar terms
Show response
John cautioned against reading dollar weakness from DXY since it only covers 6 currencies, heavily euro-weighted. Will flow through dollar weakness if it materializes broadly.
Calendar 2024 Q4
can you maybe just talk about how you think about cash or capital allocation when you're on the other side of it
Show response
John acknowledged increased flexibility in 2026 but was nonspecific on M&A or buyback plans, calling it premature to detail 2026 capital allocation.
STZConstellation Brands6 questions · 6 reporting periods · 3 of 6 challenging
Calendar 2026 Q3
Does that mean the right level is that same new higher level that you had earlier in the year?
Show response
Fink said current marketing levels are healthy and do not imply higher spend; Hankinson is comfortable with full-year spend, but no run-rate figure was given.
Calendar 2025 Q3
what can you do about it if they don't have as much money, they're not as willing to go out
Show response
Bill detailed Oro repricing to target high-end light beer, Premier repositioned at lower price point with early positive results. Price pack architecture ensures brands are available at accessible price points.
Calendar 2025 Q2
could this be sort of the equivalent of a COVID moment that even if things start to open up a bit that maybe the behavior doesn't go back to where it was
Show response
Bill distinguished between consumer interest (unchanged) and occasions (reduced), restaurants and social gatherings declining, but not a preference shift. Expects reversion when macro normalizes.
Calendar 2025 Q1
it feels like maybe some of it is structural and that could be a law of large numbers. Is there maybe a revision in expectations for Hispanic population growth
Show response
Bill denied structural issues, citing awareness gaps vs competition, shelf position runway, Modelo expansion into non-Hispanic community, and increased marketing returns.
Calendar 2024 Q4
How do you maybe think about the right amount of CapEx that you're deploying into new capacity given that we've got this slowdown
Show response
Bill emphasized modular approach to capacity, noted $1.9B remaining buyback authorization. Garth highlighted approaching cash flow inflection with bias toward returning capital to shareholders.
Calendar 2024 Q3
now that you're there, what the appetite is for more aggressively repurchasing shares
Show response
Garth detailed $450M YTD repurchases and $2.2B remaining authorization, confirming continued opportunistic buyback approach.
CLColgate-Palmolive5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2026 Q2
Is it something that snaps back later and it could be a tailwind into the back half?
Show response
Noel did not assume an inventory snap-back in guidance, focusing on driving consumption, and framed the Fresh launch as science-led and vet-driven.
Calendar 2025 Q4
for how long can that continue? Maybe there's a little promotional activity
Show response
Wallace attributed slowdown to consumer uncertainty causing pantry destocking and lower category penetration. Expects categories have bottomed but slow recovery. Sutula said FX used as flexibility in business model.
Calendar 2025 Q2
There's been some kind of debate about the category, the pet food category in general on -- if it had been fading
Show response
Wallace attributed to strategy execution not macro: therapeutic growing faster than wellness, broad-based growth across wet/dry/treats/dog/cat. Private label production ceased in July. Category flat.
Calendar 2025 Q1
do you feel like you have a sense of the sort of why behind the slowdown in February
Show response
Wallace attributed slowdown to macro uncertainty causing consumer caution and pantry destocking. Sutula noted oil down but palm/tallow up, modest net inflation expected.
Calendar 2024 Q4
If you could just talk a bit about the what's going on with volumes, particularly in Europe, is this something cyclical
Show response
Wallace attributed volume drag to private label (200bps) but highlighted 3% underlying growth, strong shares, prescription diet recovery. Sutula described RGM 2.0 as analytics-enabled pricing and promotion optimization.
Show 5 more companies
KDPKeurig Dr Pepper5 questions · 5 reporting periods · 0 of 5 challenging
Calendar 2026 Q1
Is that total company guidance? Or is it, I guess, legacy KDP?
Show response
Anthony confirmed HSG Q2 EPS guidance is total company including JDE Peet's. Free cash flow of $2.5B expected in 2026 including 9 months of JDE Peet's. Leverage targets at separation: BevCo 3.5-4x, Global Coffee Co 3.75-4.25x. Noncore asset divestitures being assessed but declined to provide specifics.
Calendar 2025 Q3
Why were they the best partners? I believe they have a Board member coming on
Show response
Jane cited strategic conviction in both successor companies from Apollo/KKR. Financial expertise and transaction experience adds value. Brian Driscoll to be nominated to board.
Calendar 2025 Q2
Do you have as much infrastructure as is necessary to be able to take on a brand of that size?
Show response
Tim explained DSD expansion strategy including Arizona acquisition, digital tools investment, and new California/Nevada/Midwest Dr Pepper distribution. Acknowledged short-term disruption from transition.
Calendar 2025 Q1
Blackberry is already 1% market share and was only lost in February. How big of a contributor will it be for the year?
Show response
Tim highlighted Dr Pepper Blackberry launched across formats (bottles, cans, fountain, frozen) and achieved nearly 1 share point in just 8 weeks. Full funnel marketing support underway.
Calendar 2024 Q4
the new, at least big, hot thing seems to be around modern soda. There's been some transactions in the place
Show response
Tim acknowledged the opportunity without committing to a specific strategy. Said 60% of portfolio is positive hydration. Would consider organic or partnerships for health-conscious white spaces.
TAPMolson Coors Beverage Company5 questions · 5 reporting periods · 3 of 5 challenging
Calendar 2026 Q2
is now the right time to be cutting costs or buying back shares as opposed to maybe really stepping it up
Show response
Rahul stressed investing first in core, Value and Above Premium brands plus Beyond Beer M&A, with disciplined cost savings and buybacks alongside. Tracey said strong cash generation lets the company fund brands, M&A and buybacks simultaneously, with priorities varying quarter to quarter.
Calendar 2026 Q1
Are there any sort of big risks or big sort of things that you're thinking about, you really want to sort of go for in this first 12 months?
Show response
Rahul pointed to aggressive portfolio transformation (Beyond Beer from ~10% of revenue with intent to grow meaningfully), reorientation to local execution, reallocation of marketing spend to occasions like live sports, and championing beer category health. Tracey said strong balance sheet provides optionality, long-term view on share value tied to sustainable growth strategy.
Calendar 2025 Q3
is this just the first step and there's bigger restructuring to come?
Show response
Rahul said more to come on total plan in coming months. The Americas restructuring was the short-term action to set up for 2026. Cost and efficiency is a super important element but committed to sharing full plan later.
Calendar 2025 Q1
we're maybe getting the earliest signs of maybe increased promotional activity or increased focus on value in some way
Show response
Gavin acknowledged continued value-seeking behavior by channel and pack but said promotional activity is not unusual, with typical summer intensity expected.
Calendar 2024 Q4
Why is sort of a small stake, the right amount with whatever P&L that contributes to your business versus the P&L that goes to the distributors
Show response
Gavin framed Fever-Tree as fitting the string-of-pearls M&A approach, slightly bigger but strategic. Canada's success attributed to broad-based brand strength, premiumization with Miller Lite and Madri, and fastest-growing RTD position.
CELHCelsius Holdings, Inc.4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q2
which leads to a weaker net all-in number than we would have expected, I think than you guys would have expected
Show response
CEO argued limited-time offers become less material as Alani's base SKU count and repeat purchase build out; general on how the comps get managed quarter to quarter.
Calendar 2025 Q3
Curious how you're thinking about the price point, not just of Celsius, but also Alani and Rockstar.
Show response
John said pricing and promotional strategy are under evaluation and a revenue-management team is being built, but declined to announce any pricing action.
Calendar 2025 Q1
we're seeing energy drinks as a category accelerate at a time where almost everything else in CPG
Show response
Fieldly credited category resilience plus a wave of health-and-wellness innovation driving consumer trial; a direct read on category health.
Calendar 2024 Q4
Can you maybe talk about the positioning of the two brands and how you plan to solve for maybe any any
Show response
Management framed Alani Nu's ~92% female consumer base as incremental with low cannibalization; a substantive, direct answer.
MNSTMonster Beverage3 questions · 3 reporting periods · 0 of 3 challenging
Calendar 2026 Q2
I'd like to dig into the commentary around the pricing. It sounds like it's some global decisions.
Show response
Rob Gehring described consistent U.S. pricing to drive revenue ahead of volume and profit ahead of revenue; Guy Carling said EMEA took aggregate low-single-digit pricing on an opportunistic basis.
Calendar 2025 Q3
A question on the contribution of affordable energy around the world and its sort of impact on margins
Show response
CEO explained international pricing constraints due to competitive dynamics. Affordable energy uses concentrate model which generates higher margins than finished goods, so will be positive but modest contributor to margin improvement.
Calendar 2025 Q1
You mentioned a bit about supply chain optimization and maybe some purchase timing from bottlers having an impact on the Q1 number
Show response
Co-CEO explained significant closure days of distribution centers by major bottlers early in Q1, plus FX, weather, and one less selling day. Pointed to robust April as correction.
CHDChurch & Dwight1 question · 1 reporting period · 0 of 1 challenging
Calendar 2025 Q1
what gives you the confidence that inventory shouldn't bounce back or that there should be a restock
Show response
CEO said order visibility shows no restock coming in Q2 due to flat/negative consumption. On promo: expects levels to rise if categories stay flat, but CHD positioned to gain share.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| PEP PepsiCo | 9 | 22%2 of 9 questions |
| PG The Procter & Gamble Company | 9 | 0%none of 9 questions |
| CLX Clorox | 8 | 25%2 of 8 questions |
| KO The Coca-Cola Company | 7 | 29%2 of 7 questions |
| STZ Constellation Brands | 6 | 50%3 of 6 questions |
| CL Colgate-Palmolive | 5 | 0%none of 5 questions |
| KDP Keurig Dr Pepper | 5 | 0%none of 5 questions |
| TAP Molson Coors Beverage Company | 5 | 60%3 of 5 questions |
| CELH Celsius Holdings, Inc. | 4 | 0%none of 4 questions |
| MNST Monster Beverage | 3 | 0%none of 3 questions |
- PEPPepsiCo · 9 questions22%2 of 9 questions
- PGThe Procter & Gamble Company · 9 questions0%none of 9 questions
- CLXClorox · 8 questions25%2 of 8 questions
- KOThe Coca-Cola Company · 7 questions29%2 of 7 questions
- STZConstellation Brands · 6 questions50%3 of 6 questions
- CLColgate-Palmolive · 5 questions0%none of 5 questions
- KDPKeurig Dr Pepper · 5 questions0%none of 5 questions
- TAPMolson Coors Beverage Company · 5 questions60%3 of 5 questions
- CELHCelsius Holdings, Inc. · 4 questions0%none of 4 questions
- MNSTMonster Beverage · 3 questions0%none of 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 4 | 0%none of 4 questions | 3 |
| 2024 Q4 | 9 | 22%2 of 9 questions | 9 |
| 2025 Q1 | 11 | 9%1 of 11 questions | 11 |
| 2025 Q2 | 7 | 29%2 of 7 questions | 7 |
| 2025 Q3 | 9 | 11%1 of 9 questions | 9 |
| 2025 Q4 | 5 | 20%1 of 5 questions | 5 |
| 2026 Q1 | 6 | 17%1 of 6 questions | 5 |
| 2026 Q2 | 8 | 38%3 of 8 questions | 8 |
| 2026 Q3 | 3 | 33%1 of 3 questions | 2 |
- 2024 Q34 questions · challenge rate 0% (none of 4 questions) · 3 companies
- 2024 Q49 questions · challenge rate 22% (2 of 9 questions) · 9 companies
- 2025 Q111 questions · challenge rate 9% (1 of 11 questions) · 11 companies
- 2025 Q27 questions · challenge rate 29% (2 of 7 questions) · 7 companies
- 2025 Q39 questions · challenge rate 11% (1 of 9 questions) · 9 companies
- 2025 Q45 questions · challenge rate 20% (1 of 5 questions) · 5 companies
- 2026 Q16 questions · challenge rate 17% (1 of 6 questions) · 5 companies
- 2026 Q28 questions · challenge rate 38% (3 of 8 questions) · 8 companies
- 2026 Q33 questions · challenge rate 33% (1 of 3 questions) · 2 companies
Topics
Topics tagged on this analyst’s questions.
- Competitive Dynamics26
- Demand22
- Capital Allocation11
- Pricing9
- Margin8
- Product Launch7
- Capex Investment5
- Innovation & R&D5
- Macroeconomic5
- Revenue Growth4
Show all 19 topics
- Geographic Expansion4
- M&A4
- Cost Pressure3
- Inventory3
- Guidance Reliability3
- Fx3
- Supply Chain2
- Trade Tariffs2
- Regulation Policy1